Q/C Technologies (QCLS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Mar, 2026Executive summary
Special Meeting scheduled for July 24, 2024, to be held virtually for all stockholders.
Four main proposals: issuance of new shares and warrants, increase in authorized shares, auditor ratification, and potential adjournment.
Board recommends voting "FOR" all proposals to support financing and operational flexibility.
Voting matters and shareholder proposals
Proposal 1 seeks approval for issuance of shares and warrants exceeding 20% of outstanding common stock, related to recent private placements.
Proposal 2 requests an amendment to increase authorized common stock from 16,666,666 to 250,000,000 shares.
Proposal 3 is for ratification of Morison Cogen LLP as independent auditor for fiscal 2024.
Proposal 4 allows adjournment of the meeting if more time is needed to solicit votes.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Joshua Silverman serves as Chairman of the Board and is the designated proxy for the meeting.
Board and management may have interests in proposals due to participation in private placements.
Latest events from Q/C Technologies
- Registering 6.5M shares for resale, with major dilution and capital needs amid business diversification.QCLS
Registration Filing6 Mar 2026 - Net loss increased to $27.2 million in 2024, with urgent need for new funding to sustain operations.QCLS
Q4 20246 Mar 2026 - Net loss narrowed, but going concern and Nasdaq compliance risks persist amid ongoing clinical development.QCLS
Q2 20256 Mar 2026 - Net loss reached $24M YTD; cash and securities at $10.6M; liquidity sufficient for 12 months.QCLS
Q3 20246 Mar 2026 - Stockholders will vote on directors, equity plan expansion, auditor ratification, and adjournment.QCLS
Proxy Filing6 Mar 2026 - Transitioned to laser-based computing for blockchain, raising $9.4M and narrowing net loss.QCLS
Q3 20256 Mar 2026 - Net loss widened to $21.3M as new financings and warrant amendments strengthened liquidity.QCLS
Q2 20246 Mar 2026 - Shareholders will vote on director elections, capital structure changes, and key governance proposals.QCLS
Proxy Filing6 Mar 2026 - Shareholders to vote on major share issuances, incentive plan expansion, and a reverse stock split.QCLS
Proxy Filing6 Mar 2026